Notification Bar Icon

Unlock 5% OFF: Shop online now and save on every purchase! Limited time offer.

Unlock 5% OFF: Shop online now and save on every purchase! Limited time offer.Learn more

Learn more
Only %1 left
SKU

Polaris® RNase Inhibitor 80 U/µL, IVD

Storage Conditions:
-85 °C to -15 °C
Polaris® RNase Inhibitor 80 U/µL, IVD, is a validated Class A IVD reagent, designed to enhance the performance, reliability, and accuracy of RT-qPCR molecular diagnostics. The protein preserves RNA integrity by inhibiting RNase activity, ensuring accurate transcription and amplification. Despite containing 50% glycerol for stability and freeze protection, its high concentration ensures minimal glycerol inclusion in master mixes, preserving compatibility with lyophilization processes.
Availability
Ready to Ship
From €1,140.00
Polaris® RNase Inhibitor 80 U/µL, IVD, designed for in vitro diagnostic (IVD) applications, is a highly robust protein inhibitor specifically engineered to enhance the performance, reliability, and accuracy of RT-qPCR molecular diagnostics. This RNase inhibitor effectively protects RNA from degradation by RNases during the critical steps of reverse transcription and nucleic acid amplification. The Polaris® RNase Inhibitor 80 U/µL, IVD, ensures optimal conditions for molecular diagnostics by inhibiting RNase activity, thus preserving the integrity of RNA samples. This protection is crucial for achieving accurate transcription and amplification, significantly reducing the likelihood of errors during these processes and enhancing the yield and specificity of the desired RT-qPCR products. Consequently, Polaris® RNase Inhibitor 80 U/µL, IVD, improves the reliability and accuracy of diagnostic RT-PCR, multiplex RT-PCR, quantitative RT-qPCR applications. Despite containing 50% glycerol to enhance stability and protect against freezing conditions, its high concentration ensures minimal glycerol incorporation into master mixes, thus maintaining compatibility with lyophilization processes. The result is a highly versatile inhibitor that retains the reproducible performance expected in diagnostic applications, even when used in lower volumes. It is specially formulated to function effectively without high concentrations of DTT, ensuring the stability of this protein inhibitor across various diagnostic workflows. Accommodating a broad spectrum of RT-qPCR requirements, Polaris® RNase Inhibitor 80 U/µL, IVD, is especially suited for challenging and multiplex RT-qPCR applications that demand rapid transcription and amplification without compromising specificity or sensitivity.

Polaris® RNase Inhibitor 80 U/µL, IVD, is produced under a rigorous quality management system according to global standards for medical devices and IVD manufacturing, including stringent quality assurance, full traceability from production, and reliability in its diagnostic applications. The efficacy of Polaris® RNase Inhibitor 80 U/µL, IVD, is especially relevant in the field of molecular diagnostics, as evidenced in this instruction manual through extensive validation for detecting a wide range of RNA viral pathogens, including SARS-CoV-2, Respiratory Syncytial Virus (RSV, subtypes A and B) and Influenza Virus (types A and B). The comprehensive validation of Polaris® RNase Inhibitor 80 U/µL, IVD, across diverse clinical matrices, establishes it as a validated Class A IVD reagent for molecular diagnostics.

Features:
  • Sensitivity and Specificity
  • Accuracy and Reproducibility
  • Stability and Robustness


Intended Use:
Polaris® RNase Inhibitor 80 U/µL, IVD, is a validated Class A IVD reagent, intended for professional use in the real-time PCR detection of RNA virus in nasopharyngeal or oropharyngeal swabs samples collected from patients. A positive result indicates the presence of pathogen RNA but a clinical correlation with patient history and other diagnostic information is necessary to determine the patient's infection status. Negative results do not preclude microbial infection and should not be used as the sole basis for patient management decisions. Thus, the results obtained with tests using this product should be interpreted in conjunction with other clinical and laboratory findings. This IVD reagent is intended for use by properly licensed laboratory professionals. The performance characteristics of this product were established based on the detection of the respiratory viruses SARS-CoV-2, Influenza types A and B, and RSV. Laboratories should validate performance for other targets according to local regulations and guidelines. The extensive validation and versatility of this enzyme underscores Polaris® RNase Inhibitor 80 U/µL, IVD, as a robust class A diagnostic reagent, capable of accommodating varied diagnostic demands and capable of delivering reliable results across different biological matrices and testing conditions.

In case the IFU is not available in your official country language, please contact us – info@NZYtech.com so that we can proceed with the translation. Please see languages available below.

Find the IFU for your product batch
More Information
Shipping Conditions Room Temperature
Storage Conditions -85 °C to -15 °C
Format Enzyme/Protein, Liquid
Product Category Polaris® RT-qPCR
Marking CE-IVD
Internal Control No
Features Stable & Robust
RI 80 U/µL
More Information
Shipping Conditions Room Temperature
Storage Conditions -85 °C to -15 °C
Format Enzyme/Protein, Liquid
Product Category Polaris® RT-qPCR
Marking CE-IVD
Internal Control No
Features Stable & Robust
More Information
Shipping Conditions Room Temperature
Storage Conditions -85 °C to -15 °C
Format Enzyme/Protein, Liquid
Product Category Polaris® RT-qPCR
Marking CE-IVD
Internal Control No
Features Stable & Robust

MSDS

Material Safety Data Sheets

CoA

Certificate of Analysis

Please insert your lot number to get the available CoA

Related Products